BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9723634)

  • 21. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure.
    Tang WH; Vagelos RH; Yee YG; Benedict CR; Willson K; Liss CL; Fowler MB
    J Am Coll Cardiol; 2002 Jan; 39(1):70-8. PubMed ID: 11755289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
    Hou YP; Wu JL; Fan Q; Liu MB; Yin BL; Zhang L
    Clin Sci (Lond); 2007 Mar; 112(5):299-304. PubMed ID: 17020540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.
    van Vliet AA; Donker AJ; Nauta JJ; Verheugt FW
    Am J Cardiol; 1993 Jan; 71(3):21A-28A. PubMed ID: 8422000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACE inhibitor dosage at the time of listing predicts survival.
    Berger R; Kuchling G; Frey B; Kozanly I; Pacher R; Stanek B
    J Heart Lung Transplant; 2000 Feb; 19(2):127-33. PubMed ID: 10703687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of angiotensin converting enzyme with enalapril maleate in infants with congestive heart failure.
    Dutertre JP; Billaud EM; Autret E; Chantepie A; Oliver I; Laugier J
    Br J Clin Pharmacol; 1993 May; 35(5):528-30. PubMed ID: 8512763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
    Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
    N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group.
    Vítovec J; Spinar J
    Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.
    Crozier I; Ikram H
    Drugs; 1992 May; 43(5):637-50. PubMed ID: 1379144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From digoxin to angiotensin-converting enzyme inhibitors: issues in pharmacotherapy for congestive heart failure.
    Hackenbruck HA
    Clin Excell Nurse Pract; 2000 Jul; 4(4):197-204. PubMed ID: 11261079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescribing and emergency admissions for heart failure in greater Glasgow.
    Davie AP; Morrison CE; Forrester JE; Mcmurray JJ
    J Card Fail; 1999 Mar; 5(1):3-7. PubMed ID: 10194654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
    Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
    Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.
    Lam PH; Dooley DJ; Fonarow GC; Butler J; Bhatt DL; Filippatos GS; Deedwania P; Forman DE; White M; Fletcher RD; Arundel C; Blackman MR; Adamopoulos C; Kanonidis IE; Aban IB; Patel K; Aronow WS; Allman RM; Anker SD; Pitt B; Ahmed A
    Eur J Heart Fail; 2018 Feb; 20(2):359-369. PubMed ID: 28980368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors.
    Guazzi M; Pontone G; Agostoni P
    Am Heart J; 1999 Aug; 138(2 Pt 1):254-60. PubMed ID: 10426836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison. The NETWORK Investigators.
    Eur Heart J; 1998 Mar; 19(3):481-9. PubMed ID: 9568453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy.
    Jensen BV; Nielsen SL; Skovsgaard T
    Lancet; 1996 Feb; 347(8997):297-9. PubMed ID: 8569365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group.
    Nanas JN; Alexopoulos G; Anastasiou-Nana MI; Karidis K; Tirologos A; Zobolos S; Pirgakis V; Anthopoulos L; Sideris D; Stamatelopoulos SF; Moulopoulos SD
    J Am Coll Cardiol; 2000 Dec; 36(7):2090-5. PubMed ID: 11127445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
    Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor].
    Pomini G; Rugna A; Lupia M; Opocher G; Gribaldo R
    G Ital Cardiol; 1992 Jul; 22(7):807-12. PubMed ID: 1473654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A survey of current use of angiotensin-converting-enzyme inhibitors by Scottish physicians in the treatment of chronic cardiac failure.
    McMurray J; Lang CC; Maclean DD; McDevitt DG; Struthers AD
    Scott Med J; 1989 Apr; 34(2):425-7. PubMed ID: 2740888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.